A Professor of Obstetrics and Gynaecology at the University of Ilorin Teaching Hospital (UITH), Ilorin, Munir-deen Ijaiya, has developed a technique for the effective treatment of vesico-vagina fistula. The biotechnological innovation was published in the recent edition of the globally renowned Int Urogynecol, a journal of the International Urogynecological Association. The technique, according to the report, is not only the pioneering effort in that branch of biotechnology but the first form of such biotechnological technique targeted at eradicating the post-treatment impact of VVF reported in any scientific literature globally. The technique, according to the report, was precipitated by the growing cases of female reproductive health challenges as a result of the increasing incidence of VVF, which is particularly prevalent in Third World countries. The report noted that the prevalence of the VVF among women of different ages has become a clear reflection of the poor obstetric initiative and general backward health care culture among the people of various developing countries, one of which is Nigeria. The report, which was well-received by the global biotechnological and medical community, was supported with verifiable case studies of VVF patients that were treated with the deployment of the technique and which resulted in the restoration of their normalcy as their vaginal capacity, unlike the hitherto situation, was also left preserved in its entirety. The technique, which had been issued patent under the label of ‘M. Ijaiya’s Technique’ by the Federal Government of Nigeria on November 12, 2018, has also been found to be particularly useful “when the anterior lip of the cervix is involved in the pressure necrosis and it is difficult to achieve a tension-free repair.” The report added that the technique has also been found to be useful in the treatment of postmenopausal patients with a normal cervical smear and endometrial biopsy.